An endless stream of personalized newsGet the App
Your dogged tenacity is your not-so-secret weapon today as you remedy an uncomfortable situation that is creating its share of stress. But you may not be able to put Humpty-Dumpty back together again as quickly as you wish. Nevertheless, giving up is not an option. Avoid the obvious shortcut; quick fixes won't last, making them a waste of your time. An extra dose of persistence empowers you to find a more permanent solution to the problem. Get Your Complete Cosmic Profile
Shares of Juno Therapeutics and Kite Pharma are weak Monday following a lackluster showing for so-called CAR-T cellular therapies in solid tumors at a closely watched cancer conference this weekend.
The shares of a number of companies that are developing CAR-T cancer therapies are falling following the annual meeting of the American Association for Cancer Research. CAR-T therapy refers to an immunotherapy approach that involves altering a patient's white blood cells to recognize and attack…
Teva Pharmaceuticals (TEVA) shares are falling after the FDA approved a generic version of its multiple sclerosis treatment.
Is this meaningful? Or just another movement?
Two major biotech conferences got underway this past weekend, and new data that was presented is already having a big impact on the stock market. Here’s a summary of what happened. CAR-T Disappointment ...